 |
市场调查报告书
商品编码
1628089
心臟假体设备市场机会、成长动力、产业趋势分析与预测 2025 - 2034 年Cardiac Prosthetic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年，全球心臟假体器材市场价值为86 亿美元，预计2025 年至2034 年复合年增长率为8.4%。老化的加剧。老年人更容易患心臟相关疾病，因此对这些设备产生了巨大的需求，特别是心臟瓣膜置换术和类似的干预措施。
装置材料、设计和微创植入技术的创新大大提高了心臟假体的安全性和效率。这些进步扩大了应用范围，为无法接受传统手术治疗的患者带来了更好的结果。心臟假体装置是治疗对药物或微创解决方案无反应的严重心血管问题的关键工具。
该市场按产品分为起搏器和心臟瓣膜，其中起搏器将在 2024 年产生最高收入。无引线设计、MRI 相容性和无线连接等先进技术透过提高患者便利性和设备功能，进一步推动市场扩张。
| 市场范围 | |
|---|---|
| 开始年份 | 2024年 |
| 预测年份 | 2025-2034 |
| 起始值 | 86 亿美元 |
| 预测值 | 194 亿美元 |
| 复合年增长率 | 8.4% |
就最终用途而言，市场分为医院、门诊手术中心和其他医疗机构。 2024 年，医院在该领域占据主导地位，预计到 2034 年将显着增长，收入达到 90 亿美元。医院的专业心臟科室越来越多地配备先进设备来处理复杂的心臟手术，使这些设施成为心臟假体的最大消费者。此外，医院正在优先考虑具有成本效益的解决方案，以提高患者的治疗效果并缩短復原时间，从而进一步增加对创新心臟设备的需求。
从地理上看，北美在 2024 年将占据 37 亿美元的市场份额，并预计在预测期内以 7.7% 的复合年增长率大幅增长。心血管疾病的高盛行率，加上对技术创新的高度重视，使该地区成为关键市场。设备设计和微创手术的不断进步正在推动医疗保健提供者的采用，确保更好的患者护理和结果。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 产业影响力
- 成长动力
- 全球心血管疾病盛行率上升
- 心臟假体装置的技术进步
- 老年族群对微创手术的偏好日益增加
- 提高对心臟病的认识和诊断
- 产业陷阱与挑战
- 设备成本高
- 缺乏熟练的医疗保健专业人员
- 成长动力
- 成长潜力分析
- 监管环境
- 报销场景
- 技术景观
- 未来市场趋势
- 差距分析
- 波特的分析
- PESTEL分析
第 4 章：竞争格局
- 介绍
- 公司矩阵分析
- 公司市占率分析
- 主要市场参与者的竞争分析
- 竞争定位矩阵
- 战略仪表板
第 5 章：市场估计与预测：按产品分类，2021 - 2034 年
- 主要趋势
- 起搏器
- 植入式心律调节器
- 体外心律调节器
- 心臟瓣膜
- 机械心臟瓣膜
- 组织心臟瓣膜
- 经导管心臟瓣膜
第 6 章：市场估计与预测：依最终用途，2021 - 2034 年
- 主要趋势
- 医院
- 门诊手术中心
- 其他最终用户
第 7 章：市场估计与预测：按地区划分，2021 - 2034 年
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
第 8 章：公司简介
- Abbott Laboratories
- Abiomed
- AtriCure
- Biotronik
- Boston Scientific Corporation
- CryoLife
- Edwards Lifesciences Corporation
- Labcor Laboratorios
- Lepu Medical Technology
- Lifetech Scientific
- LivaNova
- Medtronic
- Meril Life Sciences
- MicroPort Scientific
- Siemens Healthcare
The Global Cardiac Prosthetic Devices Market was valued at USD 8.6 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2034. This growth is driven by advancements in medical technology, an increasing prevalence of cardiovascular conditions, a growing aging population, and a rising preference for minimally invasive procedures. The elderly, being more prone to heart-related conditions, are creating significant demand for these devices, particularly for heart valve replacements and similar interventions.
Innovations in device materials, design, and minimally invasive implantation techniques have greatly enhanced the safety and efficiency of cardiac prosthetics. These advancements have broadened the scope of applications, allowing for better outcomes for patients who cannot undergo traditional surgical treatments. Cardiac prosthetic devices are critical tools for managing severe cardiovascular issues that are unresponsive to medication or less invasive solutions.
The market is segmented by product into pacemakers and heart valves, with pacemakers generating the highest revenue in 2024. The rising prevalence of arrhythmias, including conditions that disrupt normal heart rhythm, is fueling demand for pacemakers. Advanced technologies like leadless designs, MRI compatibility, and wireless connectivity are further driving market expansion by improving patient convenience and device functionality.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $8.6 Billion |
| Forecast Value | $19.4 Billion |
| CAGR | 8.4% |
In terms of end-use, the market is categorized into hospitals, ambulatory surgical centers, and other healthcare settings. Hospitals dominated the segment in 2024 and are expected to see significant growth by 2034, reaching USD 9 billion in revenue. Specialized cardiac units in hospitals are increasingly equipped with advanced devices to handle complex cardiac procedures, making these facilities the largest consumers of cardiac prosthetics. Furthermore, hospitals are prioritizing cost-effective solutions that enhance patient outcomes and reduce recovery times, further boosting demand for innovative cardiac devices.
Geographically, North America accounted for USD 3.7 billion of the market share in 2024 and is poised for substantial growth at a CAGR of 7.7% during the forecast period. The high prevalence of cardiovascular diseases, coupled with a strong focus on technological innovation, positions this region as a key market. Continuous advancements in device design and minimally invasive procedures are driving adoption among healthcare providers, ensuring better patient care and outcomes.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increase in prevalence of cardiovascular diseases across the globe
- 3.2.1.2 Technological advancements in cardiac prosthetic devices
- 3.2.1.3 Increasing preferences for minimally invasive procedures among aging population
- 3.2.1.4 Rising awareness and diagnosis for cardiac ailments
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost of the devices
- 3.2.2.2 Dearth of skilled healthcare professionals
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Reimbursement scenario
- 3.6 Technology landscape
- 3.7 Future market trends
- 3.8 Gap analysis
- 3.9 Porter's analysis
- 3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
- 5.1 Key trends
- 5.2 Pacemaker
- 5.2.1 Implantable pacemaker
- 5.2.2 External pacemakers
- 5.3 Heart valves
- 5.3.1 Mechanical heart valve
- 5.3.2 Tissue heart valve
- 5.3.3 Transcatheter heart valve
Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
- 6.1 Key trends
- 6.2 Hospitals
- 6.3 Ambulatory surgical centers
- 6.4 Other end users
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
Chapter 8 Company Profiles
- 8.1 Abbott Laboratories
- 8.2 Abiomed
- 8.3 AtriCure
- 8.4 Biotronik
- 8.5 Boston Scientific Corporation
- 8.6 CryoLife
- 8.7 Edwards Lifesciences Corporation
- 8.8 Labcor Laboratorios
- 8.9 Lepu Medical Technology
- 8.10 Lifetech Scientific
- 8.11 LivaNova
- 8.12 Medtronic
- 8.13 Meril Life Sciences
- 8.14 MicroPort Scientific
- 8.15 Siemens Healthcare
